No it's not. This is heavily regulated in Europe and Australia. They would need to pass each Phase to move to the next:
https://uk.gsk.com/en-gb/research/trials-in-people/clinical-trial-phases/
https://www.australianclinicaltrials.gov.au/what-clinical-trial/phases-clinical-trials
what could they do?, page-180
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.065(39.4%) |
Mkt cap ! $11.13M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 23.0¢ | 17.5¢ | $97.37K | 451.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 6921 | 5 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |